Page last updated: 2024-11-08

substance p (5-11)

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

substance P (5-11): RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162632
CHEMBL ID311405
SCHEMBL ID11309707
MeSH IDM0099294

Synonyms (18)

Synonym
CHEMBL311405 ,
spcthp
51165-09-4
(2s)-2-amino-n-[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-[[2-[[(2s)-1-[[(2s)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]
bdbm50283252
(s)-2-[2-((s)-2-{(s)-2-[(s)-2-((s)-2-amino-4-carbamoyl-butyrylamino)-4-carbamoyl-butyrylamino]-3-phenyl-propionylamino}-3-phenyl-propionylamino)-acetylamino]-4-methyl-pentanoic acid ((s)-1-carbamoyl-3-methylsulfanyl-propyl)-amide
SCHEMBL11309707
substance p (5-11)
substance p c-terminal heptapeptide
1-des-arg-2,4-des-pro-3-des-lys-substance p
1-dearginyl-2,4-deprolyl-3-delysine-substance p
substance p, dearginyl(1)-deprolyl(2,4)-delysine(3)-
substance p, 1-de-l-arginine-2-de-l-proline-3-de-l-lysine-4-de-l-proline-
substance p(5-11)
20-amino-11,14-dibenzyl-4,7,10,13,16,19-hexahydroxy-17-(3-hydroxy-3-iminopropyl)-5-(2-methylpropyl)-2-[2-(methylsulfanyl)ethyl]-3,6,9,12,15,18-hexaazatricosa-3,6,9,12,15,18-hexaene-1,23-diimidic acid
DTXSID30965436
CS-0626891
HY-P3890

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Naloxone antagonized this action of NP and shifted the SPF dose-response curve 4-fold to the left."( Opioid and neurokinin activities of substance P fragments and their analogs.
Lei, SZ; Lipkowski, AW; Wilcox, GL, 1991
)
0.28
" The dose-response curve was bell-shaped, the analgesic effect being smaller after the largest doses."( Blockade by met-enkephalin antiserum of analgesia induced by substance P in mice.
Del Rio, J; Naranjo, JR; Sanchez-Franco, F, 1982
)
0.26
" The dose-response curves (0."( Substance P-(1-7) and substance P-(5-11) locally modulate dopamine release in rat striatum.
Brooks, N; Khan, S; Michael-Titus, AT; Whelpton, R, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (53.85)18.7374
1990's8 (30.77)18.2507
2000's4 (15.38)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.83 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.13 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.85%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]